PDT Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,559
Closed -$1.05M 628
2026
Q1
$1.05M Hold
9,559
0.06% 331
2025
Q4
$1.59M Sell
9,559
-700
-7% -$117K 0.1% 287
2025
Q3
$2.01M Sell
10,259
-114,383
-92% -$18.8M 0.13% 252
2025
Q2
$11.3M Buy
124,642
+71,485
+134% +$5.65M 0.64% 14
2025
Q1
$3.17M Buy
53,157
+28,121
+112% +$2.6M 0.23% 150
2024
Q4
$3.32M Sell
25,036
-9,964
-28% -$935K 0.29% 113
2024
Q3
$1.83M Buy
+35,000
New +$1.64M 0.16% 229

Other funds holding ALAB

PDT Partners's ALAB Position: Q2 2026 in Review

PDT Partners sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 9,559 shares — an estimated $1.05M sold.

PDT Partners first reported a position in ALAB in Q3 2024 and held it in 7 quarters. The position peaked at $11.3M in Q2 2025. 991 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • PDT Partners reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • PDT Partners sold 9,559 Astera Labs shares in Q2 2026, an estimated $1.05M.
  • PDT Partners first reported a position in Astera Labs in Q3 2024 and held it in 7 quarters.
  • PDT Partners's Astera Labs position peaked at $11.3M in Q2 2025.
  • 991 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.